Literature DB >> 29766365

Iron overload prevents oxidative damage to rat brain after chlorpromazine administration.

Natacha E Piloni1,2, Andres A Caro3, Susana Puntarulo4,5.   

Abstract

The hypothesis tested is that Fe administration leads to a response in rat brain modulating the effects of later oxidative challenges such as chlorpromazine (CPZ) administration. Either a single dose (acute Fe overload) or 6 doses every second day (sub-chronic Fe overload) of 500 or 50 mg Fe-dextran/kg, respectively, were injected intraperitoneally (ip) to rats. A single dose of 10 mg CPZ/kg was injected ip 8 h after Fe treatment. DNA integrity was evaluated by quantitative PCR, lipid radical (LR·) generation rate by electron paramagnetic resonance (EPR), and catalase (CAT) activity by UV spectrophotometry in isolated brains. The maximum increase in total Fe brain was detected after 6 or 2 h in the acute and sub-chronic Fe overload model, respectively. Mitochondrial and nuclear DNA integrity decreased after acute Fe overload at the time of maximal Fe content; the decrease in DNA integrity was lower after sub-chronic than after acute Fe overload. CPZ administration increased LR· generation rate in control rat brain after 1 and 2 h; however, CPZ administration after acute or sub-chronic Fe overload did not affect LR· generation rate. CPZ treatment did not affect CAT activity after 1-4 h neither in control rats nor in acute Fe-overloaded rats. However, CPZ administration to rats treated sub-chronically with Fe showed increased brain CAT activity after 2 or 4 h, as compared to control values. Fe supplementation prevented brain damage in both acute and sub-chronic models of Fe overload by selectively activating antioxidant pathways.

Entities:  

Keywords:  Antioxidant; Brain; Chlorpromazine; Electron paramagnetic resonance; Fe; Oxidative stress

Mesh:

Substances:

Year:  2018        PMID: 29766365      PMCID: PMC6800076          DOI: 10.1007/s10534-018-0104-8

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  31 in total

1.  Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.

Authors:  Vinay Parikh; Mohammad M Khan; Sahebarao P Mahadik
Journal:  J Psychiatr Res       Date:  2003 Jan-Feb       Impact factor: 4.791

2.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

Review 3.  Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia.

Authors:  S P Mahadik; D Evans; H Lal
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-04       Impact factor: 5.067

4.  In vivo spin trapping of free radicals generated in brain, spleen, and liver during gamma radiation of mice.

Authors:  E K Lai; C Crossley; R Sridhar; H P Misra; E G Janzen; P B McCay
Journal:  Arch Biochem Biophys       Date:  1986-01       Impact factor: 4.013

Review 5.  Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.

Authors:  John W Newcomer
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

6.  Iron-induced oxidative brain injury after experimental intracerebral hemorrhage.

Authors:  T Nakamura; R F Keep; Y Hua; S Nagao; J T Hoff; G Xi
Journal:  Acta Neurochir Suppl       Date:  2006

Review 7.  Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis.

Authors:  Nicolas A Crossley; Miguel Constante; Philip McGuire; Paddy Power
Journal:  Br J Psychiatry       Date:  2010-06       Impact factor: 9.319

8.  Mitochondrial ferritin in animals and plants.

Authors:  Andrea Galatro; Susana Puntarulo
Journal:  Front Biosci       Date:  2007-01-01

Review 9.  Schizophrenia and comorbid metabolic disorders.

Authors:  David C Henderson
Journal:  J Clin Psychiatry       Date:  2005       Impact factor: 4.384

10.  EPR spectroscopy of chlorpromazine-induced free radical formation in normal human melanocytes.

Authors:  Michał Otręba; Magdalena Zdybel; Barbara Pilawa; Artur Beberok; Dorota Wrześniok; Jakub Rok; Ewa Buszman
Journal:  Eur Biophys J       Date:  2015-05-16       Impact factor: 1.733

View more
  4 in total

Review 1.  Genome-Protecting Compounds as Potential Geroprotectors.

Authors:  Ekaterina Proshkina; Mikhail Shaposhnikov; Alexey Moskalev
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

Review 2.  Deciphering the Iron Side of Stroke: Neurodegeneration at the Crossroads Between Iron Dyshomeostasis, Excitotoxicity, and Ferroptosis.

Authors:  Núria DeGregorio-Rocasolano; Octavi Martí-Sistac; Teresa Gasull
Journal:  Front Neurosci       Date:  2019-02-19       Impact factor: 4.677

3.  Iron Exposure and the Cellular Mechanisms Linked to Neuron Degeneration in Adult Mice.

Authors:  Lin-Bo Li; Rui Chai; Shuai Zhang; Shuang-Feng Xu; Yan-Hui Zhang; Hai-Long Li; Yong-Gang Fan; Chuang Guo
Journal:  Cells       Date:  2019-02-24       Impact factor: 6.600

4.  Effects of acute iron overload on Nrf2-related glutathione metabolism in rat brain.

Authors:  Natacha E Piloni; Romina Vargas; Virginia Fernández; Luis A Videla; Susana Puntarulo
Journal:  Biometals       Date:  2021-06-16       Impact factor: 2.949

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.